Yes. Hispanic people have melanin in their skin, just as every human being with living skin does. Melanin is not a trait some populations possess and others lack; it is a universal pigment produced by specialized cells called melanocytes. What varies across and within populations is how much melanin is made, which type dominates, and how it is packaged and distributed. Hispanic people, who trace ancestry to Spain, Latin America, and the Caribbean, show an exceptionally wide range of skin pigmentation, from very light to very dark. That range reflects mixed Indigenous American, European, and African ancestry, plus evolutionary adaptation to ultraviolet light exposure. Understanding the mechanism matters because melanin shapes sun sensitivity, vitamin D production, and skin cancer risk in ways that differ from common assumptions.

The Melanin Production Mechanism

Melanin is made inside melanocytes, which sit in the basal layer of the epidermis and extend arm-like dendrites between neighboring skin cells. Each melanocyte is paired with roughly 36 keratinocytes in what is called the epidermal melanin unit. The melanocyte produces pigment, packages it into organelles called melanosomes, and transfers those packages to keratinocytes, which carry the pigment upward as they mature toward the skin surface. This transfer, not the number of melanocytes, drives visible skin color. All human populations have essentially the same density of melanocytes in sun-exposed skin.

Two pigments matter here. Eumelanin is brown-black and absorbs broadly across ultraviolet and visible light. Pheomelanin is red-yellow and absorbs less efficiently, and its breakdown products can generate reactive oxygen species under ultraviolet stress. Most skin tones are a blend of both. The ratio and total amount determine whether skin appears ivory, olive, brown, or deep brown.

The enzyme tyrosinase catalyzes the rate-limiting step of melanin synthesis. Its activity is controlled by a receptor on the melanocyte surface called MC1R. When melanocortin signaling is strong, eumelanin production rises. When MC1R function is reduced, the balance shifts toward pheomelanin and lighter pigmentation. Genetic variants in MC1R, and in genes such as SLC24A5, SLC45A2, TYR, and OCA2, explain much of the normal variation in human skin color. None of these variants is exclusive to one ancestry group.

Ultraviolet radiation is the main environmental input. Skin darkens acutely through immediate pigment darkening and delayed tanning, and chronically through increased melanin synthesis and altered melanosome packaging. This is a protective response, not a sign of damage tolerance. The plain version: melanin is a built-in sunscreen that every person manufactures, and the dial setting varies.

Quantified Context: Skin Tone Across Hispanic Populations

Skin pigmentation is measured with reflectometry, which reports the melanin index or the individual typology angle. The individual typology angle sorts skin into categories from very light to dark. Hispanic populations span nearly the entire scale. In broad surveys of Latin American populations, skin tone correlates with self-reported ancestry, socioeconomic markers, and geography, but self-report and measured pigment often diverge.

The Fitzpatrick scale, a six-level clinical classification developed for ultraviolet phototherapy dosing, is commonly used as a proxy. It ranges from type I, which always burns and never tans, to type VI, which rarely burns. Hispanic people are represented across types I through VI. A dermatologist cannot infer Fitzpatrick type from a surname or from the label Hispanic.

Melanin index values, measured in the 400 to 700 range on many devices, also vary widely within families. Siblings can differ substantially in constitutive pigmentation because each child inherits a different combination of variants from parents with mixed ancestry. The table below compares pigment-related features across broad population categories; it describes group tendencies, not individuals.

Population category Typical melanin range Dominant pigment tendency Typical Fitzpatrick spread Note on within-group variation
Northern European Low to moderate Eumelanin with higher pheomelanin share I to III Narrower pigmentation range
Hispanic, mixed Indigenous-European Low to high Variable blend I to V Very wide; family-level differences common
Hispanic, Afro-descendant Caribbean Moderate to very high Eumelanin-dominant III to VI Wide; overlaps African populations
Indigenous American Moderate to high Eumelanin-dominant III to V Regional variation across the Americas
West African High to very high Eumelanin-dominant V to VI Narrower, generally high range
South Asian Low to very high Variable blend II to VI Very wide across the subcontinent

The key number is not a group average but the spread. Because Hispanic identity is a cultural and linguistic category rather than a genetic one, any table row labeled Hispanic hides more variation than it reveals.

Edge Cases That Break Simple Rules

Several scenarios complicate the assumption that darker skin means uniformly lower risk or that Hispanic identity predicts pigment.

People with albinism produce little or no melanin regardless of ancestry. Oculocutaneous albinism affects roughly 1 in 17,000 to 1 in 20,000 people in most populations, with higher rates in some Indigenous American and African-descended communities. A Hispanic person with albinism has extremely sun-sensitive skin and eyes, and the usual protective advice applies at maximum intensity.

Vitiligo, an autoimmune loss of melanocytes, produces depigmented patches affecting about 0.5 to 2 percent of people worldwide. It can appear in any skin tone, and in darker skin the contrast is more visible. Depigmented skin in vitiligo burns readily because it has lost its melanin shield.

Melasma, triggered by ultraviolet light and hormones, produces darkened patches on the face and is common in Hispanic women, particularly during pregnancy or with hormonal contraception. Here melanin overproduction, not deficiency, is the problem.

Post-inflammatory hyperpigmentation follows acne, eczema, or injury and is more prominent in skin with more melanin. This is a cosmetic and psychological burden, not a sign of better protection.

Drug-induced pigmentation and chemical leukoderma are further exceptions. The professional caveat: melanin amount is a poor stand-in for photoprotection in any individual, and clinical assessment of sun sensitivity requires history and sometimes measurement, not visual guesswork.

Misconceptions and What the Evidence Shows

The most persistent misconception is that melanin eliminates the need for sun protection. It reduces, but does not abolish, ultraviolet damage. Melanin absorbs a portion of ultraviolet radiation, and eumelanin is a better filter than pheomelanin. Yet people with deeply pigmented skin still accumulate DNA damage, still develop photoaging, and still get skin cancer, often at sites with less pigment such as the palms, soles, and nail beds.

A second misconception confuses skin color with vitamin D status. Vitamin D synthesis depends on ultraviolet B exposure, which darker skin converts less efficiently per unit of exposure. Hispanic adults in the United States show a higher prevalence of vitamin D deficiency than non-Hispanic White adults in national survey data. This is a nutrient status issue shaped by diet, sun exposure, body weight, and skin tone together, not a pigment defect.

A third misconception treats Hispanic as a race. The United States Census Bureau treats Hispanic origin as an ethnicity separate from race, and Hispanic people may identify as any race or as multiple races. Genetic ancestry testing often shows substantial Indigenous American, European, and African components in varying proportions. Expecting a single skin phenotype from this category is biologically incoherent.

A counterintuitive finding: darker constitutive pigmentation is associated with later-stage skin cancer diagnosis and worse survival in some United States data, partly because lesions are detected later and partly because access to dermatologic care varies. The pigment itself is protective; the health system around it is not equally protective.

For context, the American Academy of Dermatology recommends broad-spectrum sunscreen with a sun protection factor of 30 or higher for all skin tones, reapplied every two hours during exposure. That recommendation does not change with melanin amount.

Practical Actions and Thresholds

Concrete steps apply to anyone, with adjustments for pigmentation and risk.

Use broad-spectrum sunscreen labeled SPF 30 or higher on exposed skin, about one ounce for the full body, reapplied every two hours outdoors and after swimming or sweating. This is the standard threshold from dermatology societies and applies to dark and light skin alike.

Perform monthly self-skin checks. Look for new or changing lesions, and pay attention to palms, soles, under nails, and mucosal surfaces where pigment is sparse. Use the ABCDE criteria: asymmetry, border irregularity, color variation, diameter greater than 6 millimeters, and evolution over time.

See a clinician promptly for any lesion that changes, bleeds, or fails to heal within a few weeks. Do not assume a dark spot is harmless because of skin tone.

Discuss vitamin D with a clinician if you have risk factors such as limited sun exposure, darker skin, obesity, or malabsorption. Testing and supplementation decisions are individualized; do not self-prescribe high doses.

Avoid tanning beds entirely. The United States Food and Drug Administration and the Centers for Disease Control and Prevention advise against indoor tanning, and the ultraviolet doses involved add risk regardless of baseline pigment.

Warning: A changing mole or a non-healing sore on darker skin deserves the same urgent evaluation as on lighter skin. Warning: Depigmented patches from vitiligo have no melanin protection and burn quickly. Warning: Melasma and post-inflammatory hyperpigmentation can worsen with ultraviolet exposure; sun protection is treatment, not just prevention. Warning: Do not use skin-lightening products containing mercury or unapproved compounds; they cause harm and are illegal in many jurisdictions.

Limits of the Evidence and Open Questions

Skin pigmentation genetics is well characterized for major genes, but predicting an individual's pigment from ancestry is unreliable. Polygenic scores for skin color explain a meaningful share of variation in some studied populations, yet they transfer poorly across ancestries, and Hispanic populations are underrepresented in most genetic studies of pigmentation.

Clinical photoprotection thresholds are derived largely from studies in lighter-skinned populations. Evidence on optimal sunscreen use, vitamin D supplementation targets, and skin cancer screening intervals specifically in Hispanic populations remains thinner than it should be. National survey data on vitamin D deficiency use different assay methods and cutoffs, which complicates comparison across studies.

Skin cancer incidence in Hispanic populations is lower than in non-Hispanic White populations for melanoma overall, but acral melanoma, which appears on palms, soles, and nail beds, is relatively more common. The absolute numbers are small, and registry completeness varies by state and country. These are real patterns with real uncertainty around them.

What can be concluded with confidence: melanin is present in everyone, its amount varies enormously within Hispanic populations, and that variation has measurable consequences for ultraviolet sensitivity, vitamin D synthesis, and skin cancer detection. What cannot be concluded: that any individual's risk can be read from their ethnicity, their surname, or a photograph. The practical response is the same for all skin tones, applied with attention to individual pigment, history, and access to care.